APA (7th ed.) Citation

A, G., L, N., C, D. R., & RT, C. (2022). A Review of Patient-Reported Outcome Labeling of FDA-Approved New Drugs (2016-2020): Counts, Categories, and Comprehensibility. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 25(4), 647. https://doi.org/10.1016/j.jval.2021.10.006

Chicago Style (17th ed.) Citation

A, Gnanasakthy, Norcross L, DeMuro Romano C, and Carson RT. "A Review of Patient-Reported Outcome Labeling of FDA-Approved New Drugs (2016-2020): Counts, Categories, and Comprehensibility." Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research 25, no. 4 (2022): 647. https://doi.org/10.1016/j.jval.2021.10.006.

MLA (9th ed.) Citation

A, Gnanasakthy, et al. "A Review of Patient-Reported Outcome Labeling of FDA-Approved New Drugs (2016-2020): Counts, Categories, and Comprehensibility." Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 25, no. 4, 2022, p. 647, https://doi.org/10.1016/j.jval.2021.10.006.